Drugs / AOBO 001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01294982 | Dec 2010 → Nov 2011 | overactive bladder | American Oriental Bioengineering, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AOBO 001 | “Eligible patients will be randomized in equal proportions to double-blind treatment with AOBO 001 1.6 g twice daily (3.2 g daily), AOBO-001 3.2 g twice daily (6.4 g daily) or...” NCT01294982 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “AOBO-001 is a botanical (from a plant) product.” NCT01294982 ↗ |
| Route | Oral | “AOBO-001 400 mg Oral Capsules (1.6 g dose) twice daily” NCT01294982 ↗ |